ATE540692T1 - Verwendung von clostridium perfringens-typ c- bakterium zur herstellung eines impfstoffs - Google Patents

Verwendung von clostridium perfringens-typ c- bakterium zur herstellung eines impfstoffs

Info

Publication number
ATE540692T1
ATE540692T1 AT07822693T AT07822693T ATE540692T1 AT E540692 T1 ATE540692 T1 AT E540692T1 AT 07822693 T AT07822693 T AT 07822693T AT 07822693 T AT07822693 T AT 07822693T AT E540692 T1 ATE540692 T1 AT E540692T1
Authority
AT
Austria
Prior art keywords
vaccine
clostridium perfringens
bacteria
produce
perfringens type
Prior art date
Application number
AT07822693T
Other languages
German (de)
English (en)
Inventor
Maarten Hendrik Witvliet
Jozef Franciscus Maria Smeets
Keith Redhead
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Priority claimed from PCT/EP2007/062484 external-priority patent/WO2008061950A1/en
Application granted granted Critical
Publication of ATE540692T1 publication Critical patent/ATE540692T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT07822693T 2006-11-20 2007-11-19 Verwendung von clostridium perfringens-typ c- bakterium zur herstellung eines impfstoffs ATE540692T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86044706P 2006-11-20 2006-11-20
EP06124404 2006-11-20
PCT/EP2007/062484 WO2008061950A1 (en) 2006-11-20 2007-11-19 Use of clostridium perfringens type c bacterium for the manufacture of a vaccine

Publications (1)

Publication Number Publication Date
ATE540692T1 true ATE540692T1 (de) 2012-01-15

Family

ID=38535530

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07822693T ATE540692T1 (de) 2006-11-20 2007-11-19 Verwendung von clostridium perfringens-typ c- bakterium zur herstellung eines impfstoffs

Country Status (8)

Country Link
CN (1) CN101541343B (ru)
AT (1) ATE540692T1 (ru)
BR (1) BRPI0718639A2 (ru)
DK (1) DK2086578T3 (ru)
ES (1) ES2380134T3 (ru)
RU (1) RU2462263C2 (ru)
TW (1) TWI369991B (ru)
UA (1) UA95652C2 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102688484B (zh) * 2012-06-13 2016-03-30 北京中海生物科技有限公司 一种鸡坏死性肠炎（c型）灭活疫苗的生产方法
CN107789622A (zh) * 2017-10-18 2018-03-13 山东农业大学 一种犊牛肠毒血症产气荚膜梭菌β2毒素类毒素疫苗的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2129441C1 (ru) * 1997-12-10 1999-04-27 Пирожков Михаил Константинович Вакцина, ассоциированная против анаэробной энтеротоксемии и эшерихиоза поросят

Also Published As

Publication number Publication date
ES2380134T3 (es) 2012-05-08
CN101541343B (zh) 2012-05-16
DK2086578T3 (da) 2012-05-14
TW200831121A (en) 2008-08-01
CN101541343A (zh) 2009-09-23
RU2009123478A (ru) 2010-12-27
BRPI0718639A2 (pt) 2013-11-26
UA95652C2 (ru) 2011-08-25
TWI369991B (en) 2012-08-11
RU2462263C2 (ru) 2012-09-27

Similar Documents

Publication Publication Date Title
BR112012014082A2 (pt) composições e métodos que compreendem variantes de protease
GEP20156309B (en) Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
BRPI1015043A2 (pt) derivados de diazahomoadamantano e métodos de uso dos mesmos
BRPI1009637A2 (pt) composto, composição e uso de um composto
TN2011000187A1 (en) Organic compounds
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
EA201071315A1 (ru) Ингибиторы протеазы вируса гепатита с
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
CO6311079A2 (es) Derivados de aminodihidrotiazina como inhibidores de la enzima bace para el tratamiento de la enfermedad de alzheimer
CY1116383T1 (el) Αντιβακτηριακες ενωσεις
BR112012011328A2 (pt) inibidores de akt
ECSP10010722A (es) Compuestos orgánicos
ATE449097T1 (de) Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
EA201000329A1 (ru) Циклические депсипептиды
EA201001024A1 (ru) Обработка растений банана и картофеля с помощью новой противогрибковой композиции
NZ588999A (en) Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
ATE491446T1 (de) Ligustilid zur behandlung von erkrankungen des zentralen nervensystems
PA8855001A1 (es) Monocarbamas
EP2588121A4 (en) C5A ANALOGUE AND USE METHOD THEREFOR
BRPI0720050A2 (pt) 6-oxo-1,6-diidropirimidin-2-ilas no tratamento de doenças proliferativas
BR112012019565A2 (pt) formulações antimicrobianas com base em polissacarídeo
UA110332C2 (en) Use of 2,3-dihydroxypropyldodecanoate for treatment of seborrhea
NI201200104A (es) NUEVOS DERIVADOS DE (HETEROCICLO - PIPERIDINA CONDENSADA ) - ( PIPERAZINIL ) - 1 - ALCANONA O DE ( HETEROCICLO - PIRROLIDINA CONDENSADA ) - ( PIPERAZINIL ) - 1 - ALCANONA Y SU UTILIZACIÓN COMO INHIBIDORES DE p75
MX2009005117A (es) Uso de bacteria clostridium perfringens de tipo c para la elaboracion de una vacuna.